Search Results 1741-1750 of 4553 for 留痕官网咨询邮箱：lgooxc@hotmail.com

  1. Teng Moua, M.D. - Mayo Clinic Faculty Profiles

    Mayo Clinic researcher Teng Moua, M.D., focuses on fibrotic interstitial lung disease.

  2. Dent Disease Mutation Genotyping - Clinical Trials

    About this study. This study will help the investigator determine whether certain genetic mutations, more than others, are a cause of more severe disease in ...

  3. Laminectomy - Doctors & Departments - Mayo Clinic

    Departments and specialties. Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, ...

  4. Non-Hodgkin lymphoma - Doctors and departments - Mayo Clinic

    Learn about the symptoms, risk factors and treatment of this cancer of the lymphatic system that causes swollen lymph nodes.

  5. Non-Hodgkin lymphoma - Doctors and departments - Mayo Clinic

    Learn about the symptoms, risk factors and treatment of this cancer of the lymphatic system that causes swollen lymph nodes.

  6. Non-Hodgkin lymphoma - Doctors and departments - Mayo Clinic

    Learn about the symptoms, risk factors and treatment of this cancer of the lymphatic system that causes swollen lymph nodes.

  7. Non-Hodgkin lymphoma - Doctors and departments - Mayo Clinic

    Learn about the symptoms, risk factors and treatment of this cancer of the lymphatic system that causes swollen lymph nodes.

  8. Faculty - Center for Individualized Medicine - Mayo Clinic Research

    Jackson, Pamela R. Ph.D. Jackson.Pamela@mayo.edu; Assistant Professor of Biomedical Engineering; Assistant Professor of Neurosurgery. Jaffe, Allan S. M.D..

  9. Eligibility - Center for Clinical and Translational Science

    Eligibility. Benefactor-Funded Research Mid-Career Development Awards support candidates who are no longer eligible for "Early Stage Investigator" status ...

  10. Rituximab Plus Lenalidomide for Patients With Relapsed / Refractory Indolent Non-Hodgkin's Lymphoma (Follicular Lymphoma and Marginal Zone Lymphoma) - Mayo Clinic

    This double-blind randomized, parallel group study will evaluate the efficacy and safety of lenalidomide (Revlimid, CC-5013) in combination with rituximab ( ...